T1	Participants 312 414	prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
T2	Participants 763 774	36 patients
T3	Participants 1138 1149	72 patients
T4	Participants 1242 1253	31 patients
T5	Participants 1995 2039	patients with positive voided urine cytology
